19 results
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
steroids to treat infectious ... respiratory distress syndrome ... #Pharmacology # ... Management #Treatment ... #Indications
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... Prophylaxis) Indication ... amphotericin B, 3 to 5 mg/kg ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
., 4 mg/kg on days ... Leishmaniasis Indication ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Cytokine Activation Syndrome ... Tocilizumab 4-8mg/kg ... respiratory tract infection ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
Complex Regional Pain Syndrome (CRPS) - Treatment
Non-Pharmacologic:
 • Education
 • Physical & occupational therapy
 • Psychology
Regional Pain Syndrome ... Treatment Non-Pharmacologic ... behavioral therapy) Medications ... Trigger point injections ... #Treatment #Management
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Clinical Disease Indication ... Nifurtimox 8–10 mg/kg ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
best prevented by using ... other factors (e.g ... ., concomitant medications ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Encephalitis in HIV-AIDS Indications ... opportunistic #infections ... #HIVAIDS #management ... #pharmacology # ... pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... take any other medications ... been shown non-inferior ... semaglutide #Diabetes #Pharmacology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Preeclampsia, Eclampsia, Infection ... on MRA/CTA • Anterior ... Diagnosis: • Infection ... Electrolyte abnormality, Medication ... #diagnosis #management